RFA technology is used to treat a wide range of medical conditions. It is used in the treatment of tumour spot, to treat patients suffering from the adrenal gland, breast, bone, kidney, liver, lung, pancreatic, and thyroid cancer.

The market for Radiofrequency Ablation Devices was estimated to be worth $ 3.2 billion in 2021, and it is anticipated to increase to $ 11.3 billion by 2027, with a CAGR of 11.9% during forecast period 2022 and 2027.

The market for Radiofrequency Ablation Devices was estimated to be worth $ 3.2 billion in 2021, and it is anticipated to increase to $ 11.3 billion by 2027, with a CAGR of 11.9% during forecast period 2022 and 2027.